Relaxation of insulin-like growth factor-2 imprinting in rat cultured cells

Molecular and Cellular Endocrinology

Volumn 135, Issue 2, 1997, Pages 153-163

  Ungaro, Paola ^a   Casola, Stefano ^a   Vernucci, Maria ^a   Pedone, Paolo V ^a   Bruni, Carmelo B ^a   Riccio, Andrea ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

DNA methylation; Genomic imprinting; H19; Insulin like growth factor; Rat

Indexed keywords

RNA; SOMATOMEDIN B; TRYPSIN;

ANIMAL CELL; ARTICLE; CANCER SUSCEPTIBILITY; CELL CULTURE; CROSS BREEDING; DILUTION; DNA METHYLATION; EMBRYONAL CARCINOMA; GENE EXPRESSION REGULATION; GENOME IMPRINTING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT;

ANIMALS; CELL DIVISION; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; GENES; GENOMIC IMPRINTING; INSULIN-LIKE GROWTH FACTOR II; MALE; METHYLATION; MUSCLE PROTEINS; RATS; RATS, INBRED F344; RATS, WISTAR; RNA, UNTRANSLATED; TIME FACTORS;

EID: 0031566012     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(97)00201-3     Document Type: Article

References (45)

1. Albrecht S., von Schweinitz D., Waha A., Kraus A.J., von Deimling A., Pietsh T. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. Cancer Res. 54:1994;5041-5044.
2. Bartolomei M.S., Webber A.L., Brunkow M., Tilghman S.M. Epigenetic mechanism underlying the imprinting of the mouse H19 gene. Genes Dev. 7:1993;1663-1673.
3. Brandeis M., Kafri T., Arlel M., Chaillet J.R., McCarrey J., Razin A., Cedar H. The ontogeny of allele-specific methylation associated with imprinted genes in the mouse. EMBO J. 12:1993;3669-3677.
4. Brouty-Boyè D., Gresser I., Baldwin C. Reversion of the transformed phenotype to the parental phenotype by subcultivation of X-ray-transformed C3H/10T1/2 cells at low cell density. Int. J. Cancer. 24:1979;253-260.
5. Casola S., Pedone P.V., Cavazzana A.O. et al. Expression, and parental imprinting of the H19 gene in human rhabdomyosarcoma. Oncogene. 14:1997;1503-1510.
6. Casola S., Ungaro P., Pedone P.V. et al. Loss of heterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinomas. Oncogene. 11:1995;711-721.
7. Chiariotti L., Brown A.L., Frunzio R., Clemmons D.R., Rechler M.M., Bruni C.B. Structure of the rat insulin-like growth factor II transcriptional unit. Heterogeneous transcripts are generated from two promoters by use of multiple polyadenylation sites, and differential RNA splicing. Mol. Endocrinol. 2:1988;1115-1126.
8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
9. Efstratiadis A. Parental imprinting of autosomal mammalian genes. Curr. Opin. Genet. Dev. 4:1994;265-280.
10. Eversole-Cire P., Ferguson-Smith A.C., Surani M.A., Jones P.A. Coordinate regulation of Igf-2, and H19 in cultured cells. Cell Growth Differ. 6:1995;337-345.
11. Feil R., Walter J., Allen N.D., Reik W. Developmental control of allelic methylation in the imprinted mouse Igf2, and H19 genes. Development. 120:1994;2933-2943.
12. Feinberg A.P., Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137:1984;266-267.
13. Frunzio R., Chiariotti L., Brown A.L., Graham D.E., Rechler M.M., Bruni C.B. Structure, and expression of the rat insulin-like growth factor II (rIGF-II) gene. J. Biol. Chem. 261:1986;17138-17149.
14. Grundel R., Rubin H. Effect of interclonal heterogeneity on the progressive, confluence-mediated acquisition of the focus-forming phenotype in NIH-3T3 populations. Cancer Res. 51:1991;1003-1013.
15. Hao Y., Crenshaw T., Moulton T., Newcomb E., Tycko B. Tumor-suppressor activity of H19 RNA. Nature. 365:1993;764-767.
16. Issa J.P.J., Vertino P.M., Boehm C.D., Newsham I.F., Baylin S.B. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc. Natl. Acad. Sci. USA. 93:1996;11757-11762.
17. John R. M., Surani M.A. Imprinted genes, and regulation of gene expression by epigenetic inheritance. Curr. Opin. Cell Biol. 8:1996;348-353.
18. Lee L.W., Tsao M.S., Grisham J.W., Smith G.J. Emergence of neoplastic transformants spontaneously or after exposure to N-methyl-N′-nitro-N-nitrosoguanidine in populations of rat liver epithelial cells cultured under selective, and nonselective conditions. Am. J. Pathol. 135:1989;63-71.
19. Leibovitch M.P., Solhonne B., Guillier M., Verelle P., Leibovitch S.A. Direct relationship between the expression of tumor suppressor H19 mRNA, and c-mos proto-oncogene during myogenesis. Oncogene. 10:1995;251-260.
20. Leighton P.A., Ingram R.S., Eggenschwiler J., Efstratiadis A., Tilghmann S.M. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature. 375:1995a;34-39.
21. Leighton P.A., Saam J.R., Ingram R.S., Stewart C.L., Tilghman S.M. An enhancer deletion affects both H19, and Igf2 expression. Genes & Dev. 9:1995b;2079-2089.
22. Li E., Beard C., Jaenisch R. The role of DNA methylation in genomic imprinting. Nature. 366:1993;362-365.
23. Macaulay V.M. Insulin-like growth factors, and cancer. Br. J. Cancer. 65:1992;311-320.
24. Melton D.A., Krieg P.A., Rebagliati M.R., Maniatis T., Zinn K., Green M.R. Efficient in vitro synthesis of biologically active RNA, and RNA hybridization probes from plasmids containing a bacteriophage Sp6 promoter. Nucleic Acids Res. 12:1984;7035-7056.
25. Morison I.M., Becroft D.M., Taniguchi T., Woods C.G., Reeve A.E. Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nat. Med. 2:1996;311-316.
26. Moulton T., Crenshaw T., Hao Y. Epigenetic lesions at the H19 locus in Wilms' tumor patients. Nat. Genet. 7:1994;440-447.
27. Ogawa O., Eccles M.R., Szeto J. et al. Relaxation of Insulin-like growth factor II gene imprinting i Wilms' tumour. Nature. 362:1993;749-751.
28. Pal N., Wadey R.B., Buckle B., Yeomans E., Pritchard J., Cowell J.K. Preferential loss of maternal alleles in sporadic Wilms' tumour. Oncogene. 5:1990;1665-1668.
29. Pedone P.V., Cosma M.P., Ungaro P., Colantuoni V., Bruni C.B., Zarrilli R., Riccio A. Parental imprinting of rat Insulin-like Growth Factor II gene promoters is coordinately regulated. J. Biol. Chem. 269:1994a;23970-23975.
30. Pedone P.V., Tirabosco R., Cavazzana A.O. et al. Mono-, and bi-allelic expression of Insulin-like Growth Factor II gene in human muscle tumors. Hum. Mol. Genet. 7:1994b;1117-1121.
31. Rainier S., Feinberg A.P. Genomic imprinting, DNA methylation, and cancer. J. Natl. Cancer Inst. 86:1994;753-759.
32. Rainier S., Johnson L.A., Dobry C.J., Ping A.J., Grundy P.E., Feinberg A.P. Relaxation of imprinted genes in human cancer. Nature. 362:1993;747-749.
33. Rubin A.L., Yao A., Rubin H. Relation of spontaneous transformation in cell culture to adaptive growth and clonal heterogeneity. Proc. Natl. Acad. Sci. USA. 87:1990;482-486.
34. Rubin H., Xu K. Evidence for the progressive, and adaptive nature of spontaneous transformation in the NIH 3T3 cell line. Proc. Natl. Acad. Sci. USA. 86:1989;1860-1864.
35. Rubin R., Baserga R. Biology of disease: Insulin-like growth factor-I receptor. Lab. Investig. 73:1995;311-331.
36. Sambrook, J., Fritsch, E.F., Maniatis, T., 1989. Molecular Cloning, A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
37. Scrable H., Cavanee W., Ghavimi F., Lovell M., Morgan K., Sapienza C. Model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc. Natl. Acad. Sci. USA. 86:1989;7480-7484.
38. Steenman M.J, Rainier S., Dobry C.J., Grundy P., Horon I.L., Feinberg A.P. Loss of imprinting of IGF2 is linked to reduced expression, and abnormal methylation of H19 in Wilms' tumour. Nat. Genet. 3:1994;433-439.
39. Taniguchi T., Sullivan M.J., Ogawa O., Reeve A.E. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting, and silencing of H19 in Wilms' tumor. Proc. Natl. Acad. Sci. USA. 92:1995;2159-2163.
40. Todaro G.J., Green H. Quantitative studies of the growth of mouse embryo cells in culture, and their development into established lines. J. Cell. Biol. 17:1963;299-313.
41. Toretsky J.A., Helman L.J. Involvement of IGF-II in human cancer. J. Endocrinol. 149:1996;367-372.
42. Tycko B. Genomic imprinting: mechanism and role in human pathology. Am. J. Pathol. 144:1994;431-443.
43. Weksberg R., Shem D.R., Song Q.L., Squire J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat. Genet. 5:1993;143-149.
44. Yuan L., Qian N., Tycko B. An extended regin of biallelic gene expression and rodent-human synteny downstream of the imprinted H19 gene on chromosome 11p15.5. Hum. Mol. Genet. 12:1996;1931-1937.
45. Zhan S., Shapiro D.N., Helman L.J. Activation of an imprinted allele of the insuline-like growth factor II gene implicated in rhabdomyosarcoma. J. Clin. Invest. 94:1994;445-448.